Brief: Nexsen Appoints MCRA To Accelerate US Market Entry For GBS Rapid Sensor & Kidney Function Diagnostics
06/11/2025 01:27
Nov 6 (Reuters) - Nexsen Ltd NXN.AX: APPOINTMENT OF MCRA TO ACCELERATE US MARKET ENTRY FOR GBS RAPID SENSOR & KIDNEY FUNCTION DIAGNOSTICS Further company coverage: NXN.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nexsen
See all newsBrief: Nexsen Appoints Professor Shekhar Kumta As Executive Director
Brief: Nexsen Entered Into Non-Binding Term Sheet With Flashdx Shenzhen To Establish JV
Brief: Nexsen Requests Trading Halt
Brief: Nexsen Secures First Hospital Partner In Asia
Australia's Nexsen surges on collaboration with Malaysia's IHH unit